Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha.
paper
Cited
Public
Unavailable
- Authors
- Fu, Jin; Gaetani, Silvana; Oveisi, Fariba; Lo Verme, Jesse; Serrano, Antonia; RodrΓguez De Fonseca, Fernando; Rosengarth, Anja; Luecke, Hartmut; Di Giacomo, Barbara; Tarzia, Giorgio; Piomelli, Daniele
- Year
- 2003
- Journal
- Nature
- PMID
- 12955147
- DOI
- 10.1038/nature01921
Oleylethanolamide (OEA) is a naturally occurring lipid that regulates satiety and body weight. Although structurally related to the endogenous cannabinoid anandamide, OEA does not bind to cannabinoid receptors and its molecular targets have not been defined. Here we show that OEA binds with high affinity to the peroxisome-proliferator-activated receptor-alpha (PPAR-alpha), a nuclear receptor that regulates several aspects of lipid metabolism. Administration of OEA produces satiety and reduces body weight gain in wild-type mice, but not in mice deficient in PPAR-alpha. Two distinct PPAR-alpha agonists have similar effects that are also contingent on PPAR-alpha expression, whereas potent and selective agonists for PPAR-gamma and PPAR-beta/delta are ineffective. In the small intestine of wild-type but not PPAR-alpha-null mice, OEA regulates the expression of several PPAR-alpha target genes: it initiates the transcription of proteins involved in lipid metabolism and represses inducible nitric oxide synthase, an enzyme that may contribute to feeding stimulation. Our results, which show that OEA induces satiety by activating PPAR-alpha, identify an unexpected role for this nuclear receptor in regulating behaviour, and raise possibilities for the treatment of eating disorders.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Emerging natural products against obesity and metabolic dysfunction-associated steatotic liver disease/metabolic dysfunction-associated steatohepatitis: Direct target discovery and mechanistic insights. | Hu W et al. | β | 2026 | β |
| Ferroptosis of smooth muscle cells in vascular diseases: from basic principles to clinical translation. | Yang Y et al. | β | 2026 | β |
| Microbial 10-oxostearic acid protects mice against colitis via the nuclear receptor PPARΞ±. | Liu J et al. | β | 2026 | β |
| Sex-specific association between low oral doses of cannabidiol (CBD) and plasma concentration of anandamide (AEA), N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) in healthy occasional cannabis users. | Abboud A et al. | β | 2026 | β |
| The Role of Cannabinoids and the Endocannabinoid System in the Treatment and Regulation of Nausea and Vomiting. | Rock EM et al. | β | 2026 | β |
| Uncovering the pleiotropic effects of oleoylethanolamide on obesity-driven chronic kidney disease in mice. | Comella F et al. | β | 2026 | β |
| A Review of Bavachinin and Its Derivatives as Multi-Therapeutic Agents. | Zeng JL et al. | β | 2025 | β |
| Association of Serum Endocannabinoid Levels with Pancreatitis and Pancreatitis-Related Pain. | Goodman MT et al. | β | 2025 | β |
| A synergic GLP-1/Acylethanolamide-based combined therapy for MAFLD: Studies in rat models. | Ceglia M et al. | β | 2025 | β |
| Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. | Al Subait A et al. | β | 2025 | β |
| Effect of cannabinoids on the efficacy and side effects of anticancer therapeutic strategies - Current status of preclinical and clinical research. | Ramer R et al. | β | 2025 | β |
| Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats. | Okada M et al. | β | 2025 | β |
| Endocannabinoid signaling in epilepsy. | Zeng C et al. | β | 2025 | β |
| Enzyme-responsive oleoylethanolamide-releasing nanomedicine for sustained liver delivery and therapeutic improvement in early-stage metabolic dysfunction-associated steatohepatitis (MASH). | Ding Y et al. | β | 2025 | β |
| Evolutionary study and structural basis of proton sensing by Mus GPR4 and Xenopus GPR4. | Wen X et al. | β | 2025 | β |
| Global Metabolite Profiling in Feces, Serum, and Urine Yields Insights into Energy Balance Phenotypes Induced by Diet-Driven Microbiome Remodeling. | Igudesman D et al. | β | 2025 | β |
| Influence of Olive Oil Components on Ion Channels. | Mijares-Andrade H et al. | β | 2025 | β |
| Investigation of endocannabinoids in plasma and their correlation with physical fitness and resting state functional connectivity of the periaqueductal grey in women with fibromyalgia: An exploratory secondary study. | Ghafouri B et al. | β | 2025 | β |
| Liver Metabolism at the Crossroads: The Reciprocal Control of Nutrient-Sensing Nuclear Receptors and Autophagy. | Kim EY et al. | β | 2025 | β |
| Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndrome. | Cozzolino KA et al. | β | 2025 | β |
| N-Acylethanolamines in cancer: mechanisms and therapeutic potential of lipid regulators of tumor behavior. | NanΓ¬ MF et al. | β | 2025 | β |
| Neuroprotective, anti-inflammatory, and analgesic activity of palmitoylethanolamide in sickle cell mice. | Argueta DA et al. | β | 2025 | β |
| Oleoylethanolamide ameliorates collagen-induced rheumatoid arthritis via activation of GPR119. | Lee JE et al. | β | 2025 | β |
| Oleoylethanolamide-producing Lactobacillus paracasei F19 improves metabolic and behavioral disorders by restoring intestinal permeability and microbiota-gut-brain axis in high-fat diet-induced obese male mice. | Seguella L et al. | β | 2025 | β |
| Oleoylethanolamide supplementation on cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials. | Bahari H et al. | β | 2025 | β |
| Pharmacological potential of endocannabinoid and endocannabinoid-like compounds in protecting intestinal structure and metabolism under high-fat conditions. | Vari F et al. | β | 2025 | β |
| Python-derived 16Ξ±-Hydroxylated Bile Acid, Pythocholic Acid is a ligand for TGR5, not farnesoid X receptors and vitamin D receptors. | Kiaei N et al. | β | 2025 | β |
| Select microbial metabolites in the small intestinal lumen regulate vagal activity via receptor-mediated signaling. | Jameson KG et al. | β | 2025 | β |
| Study on the mechanism of <i>Xanthoceras sorbifolia</i> Bunge oil in the treatment of Alzheimer's disease by an integrated "network pharmacology-metabolomics" strategy. | Du L et al. | β | 2025 | β |
| The effect of oleoylethanolamide supplementation on cardiometabolic factors: a systematic review and meta-analysis. | Eslahi M et al. | β | 2025 | β |
| The endocannabinoid and paracannabinoid systems in natural reward processes: possible pharmacological targets? | Friuli M et al. | β | 2025 | β |
| The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets. | Iannotti FA et al. | β | 2025 | β |
| The PLAAT family as phospholipid-related enzymes. | Uyama T et al. | β | 2025 | β |
| Treating chronic stress and chronic pain by manipulating gut microbiota with diet: can we kill two birds with one stone? | Costa A et al. | β | 2025 | β |
| Aged microbiota exacerbates cardiac failure by PPARΞ±/PGC1Ξ± pathway. | Xu H et al. | β | 2024 | β |
| A human gut <i>Faecalibacterium prausnitzii</i> fatty acid amide hydrolase. | Cheng J et al. | β | 2024 | β |
| Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol. | Jieu B et al. | β | 2024 | β |
| A Sensitive Ultrahigh-Performance Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Analysis of Phytocannabinoids and Endocannabinoids in Plasma and Brain. | Ahmed F et al. | β | 2024 | β |
| Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis. | Dubbioso R et al. | β | 2024 | β |
| Decoding Allosteric Control in Hypoxia-Inducible Factors. | Zhuang J et al. | β | 2024 | β |
| Evolutionarily related host and microbial pathways regulate fat desaturation in C. elegans. | Fox BW et al. | β | 2024 | β |
| From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer. | Zhou Y et al. | β | 2024 | β |
| Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats. | Tovar R et al. | β | 2024 | β |
| Inhibition of fatty acid binding protein-5 in the basolateral amygdala induces anxiolytic effects and accelerates fear memory extinction. | Jones MJ et al. | β | 2024 | β |
| Intestinal Ketogenesis and Permeability. | Casselbrant A et al. | β | 2024 | β |
| Lipid metabolites and nitric oxide production in the cerebrospinal fluid and plasma of dogs with meningoencephalitis of unknown origin and idiopathic epilepsy: a pilot study. | Yonezawa T et al. | β | 2024 | β |
| Multi-omics landscape of childhood simple obesity: novel insights into pathogenesis and biomarkers discovery. | Ren Y et al. | β | 2024 | β |
| NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice. | Fotio Y et al. | β | 2024 | β |
| NAPE-PLD in the ventral tegmental area regulates reward events, feeding and energy homeostasis. | Castel J et al. | β | 2024 | β |
| Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease. | Dubois V et al. | β | 2024 | β |
| Serum levels of endocannabinoids and related lipids in painful vs painless diabetic neuropathy: results from the Pain in Neuropathy Study. | BΓ€ckryd E et al. | β | 2024 | β |
| The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial. | Ostadrahimi A et al. | β | 2024 | β |
| ABHD4 regulates adipocyte differentiation inΒ vitro but does not affect adipose tissue lipid metabolism in mice. | Seramur ME et al. | β | 2023 | β |
| Administration of Linoleoylethanolamide Reduced Weight Gain, Dyslipidemia, and Inflammation Associated with High-Fat-Diet-Induced Obesity. | Tovar R et al. | β | 2023 | β |
| Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. | Mock ED et al. | β | 2023 | β |
| Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients. | Herrera-Imbroda J et al. | β | 2023 | β |
| Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder. | Herrera-Imbroda J et al. | β | 2023 | β |
| Dietary fat restriction affects brain reward regions in a randomized crossover trial. | Darcey VL et al. | β | 2023 | β |
| Distribution of an analgesic palmitoylethanolamide and other N-acylethanolamines in human placental membranes. | Svobodova A et al. | β | 2023 | β |
| Effect of Oleoylethanolamide-Based Dietary Supplement on Systemic Inflammation in the Development of Alimentary-Induced Obesity in Mice. | Ivashkevich D et al. | β | 2023 | β |
| Effects of oleoylethanolamide supplementation on inflammatory biomarkers, oxidative stress and antioxidant parameters of obese patients with NAFLD on a calorie-restricted diet: A randomized controlled trial. | Tutunchi H et al. | β | 2023 | β |
| Effects of oleoylethanolamide supplementation on the expression of lipid metabolism-related genes and serum NRG4 levels in patients with non-alcoholic fatty liver disease: A randomized controlled trial. | Tutunchi H et al. | β | 2023 | β |
| Evaluation of 147 perfluoroalkyl substances for immunotoxic and other (patho)physiological activities through phenotypic screening of human primary cells. | Houck KA et al. | β | 2023 | β |
| Fenofibrate Decreases Ethanol-Induced Neuroinflammation and Oxidative Stress and Reduces Alcohol Relapse in Rats by a PPAR-Ξ±-Dependent Mechanism. | IbÑñez C et al. | β | 2023 | β |
| Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years. | Maccarrone M et al. | β | 2023 | β |
| Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis. | De Filippo C et al. | β | 2023 | β |
| HMBA ameliorates obesity by MYH9- and ACTG1-dependent regulation of hypothalamic neuropeptides. | Park S et al. | β | 2023 | β |
| MG53: A potential therapeutic target for kidney disease. | Ke B et al. | β | 2023 | β |
| Nuclear hormone receptor NHR-49 is an essential regulator of stress resilience and healthy aging in <i>Caenorhabditis elegans</i>. | Doering KRS et al. | β | 2023 | β |
| Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARΞ±. | Chen Z et al. | β | 2023 | β |
| Oleoylethanolamide facilitates PPARΞ± and TFEB signaling and attenuates AΞ² pathology in a mouse model of Alzheimer's disease. | Comerota MM et al. | β | 2023 | β |
| Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARΞ±-Mediated Microglia/Macrophage M2 Polarization. | Li Y et al. | β | 2023 | β |
| Oleoylethanolamide Treatment Modulates Both Neuroinflammation and Microgliosis, and Prevents Massive Leukocyte Infiltration to the Cerebellum in a Mouse Model of Neuronal Degeneration. | PΓ©rez-MartΓn E et al. | β | 2023 | β |
| PPARΞ± Inhibits Astrocyte Inflammation Activation by Restoring Autophagic Flux after Transient Brain Ischemia. | Luo D et al. | β | 2023 | β |
| Quantification of Analgesic and Anti-Inflammatory Lipid Mediators in Long-Term Cryopreserved and Freeze-Dried Preserved Human Amniotic Membrane. | Vrkoslav V et al. | β | 2023 | β |
| Ramulus Cinnamomi essential oil exerts an anti-inflammatory effect on RAW264.7Β cells through N-acylethanolamine acid amidase inhibition. | Jia W et al. | β | 2023 | β |
| Reducing Dietary Polyunsaturated to Saturated Fatty Acids Ratio Improves Lipid and Glucose Metabolism in Obese Zucker Rats. | Carta G et al. | β | 2023 | β |
| The 16Ξ±-hydroxylated Bile Acid, Pythocholic Acid Decreases Food Intake and Increases Oleoylethanolamide in Male Mice. | Higuchi S et al. | β | 2023 | β |
| The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders. | Mir HD et al. | β | 2023 | β |
| "To brain or not to brain": evaluating the possible direct effects of the satiety factor oleoylethanolamide in the central nervous system. | Romano A et al. | β | 2023 | β |
| Transcriptomic (DNA Microarray) and Metabolome (LC-TOF-MS) Analyses of the Liver in High-Fat Diet Mice after Intranasal Administration of GALP (Galanin-like Peptide). | Takenoya F et al. | β | 2023 | β |
| A Duet Between Histamine and Oleoylethanolamide in the Control of Homeostatic and Cognitive Processes. | Provensi G et al. | β | 2022 | β |
| Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats. | Le Bacquer O et al. | β | 2022 | β |
| Attenuation of oleoylethanolamide-induced reduction of alcohol consumption in adult rats exposed intermittently to alcohol during adolescence. | SΓ‘nchez-MarΓn L et al. | β | 2022 | β |
| Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity. | Charytoniuk T et al. | β | 2022 | β |
| Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases. | Ramer R et al. | β | 2022 | β |
| Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility. | PrzybycieΕ P et al. | β | 2022 | β |
| Dietary oleic acid contributes to the regulation of food intake through the synthesis of intestinal oleoylethanolamide. | Igarashi M et al. | β | 2022 | β |
| Effects of Intra-BLA Administration of PPAR Antagonists on Formalin-Evoked Nociceptive Behaviour, Fear-Conditioned Analgesia, and Conditioned Fear in the Presence or Absence of Nociceptive Tone in Rats. | Gaspar JC et al. | β | 2022 | β |
| Effects of peroxisome proliferator activated receptor-Ξ± agonist on growth performance, blood profiles, gene expression related to liver fat metabolism in broilers fed diets containing corn naturally contaminated with mycotoxins. | Zhang Y et al. | β | 2022 | β |
| Endocannabinoid-Based Therapies. | Piomelli D et al. | β | 2022 | β |
| Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation. | Aibara D et al. | β | 2022 | β |
| Hormone-sensitive lipase is localized at synapses and is necessary for normal memory functioning in mice. | Skoug C et al. | β | 2022 | β |
| Identification of oleoylethanolamide as an endogenous ligand for HIF-3Ξ±. | Diao X et al. | β | 2022 | β |
| Impact of Cannabinoid Compounds on Skin Cancer. | Ramer R et al. | β | 2022 | β |
| Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms. | Xu C et al. | β | 2022 | β |
| Investigating the Long-Term Effect of an Interdisciplinary Multimodal Rehabilitation Program on Levels of Bioactive Lipids and Telomerase Activity in Blood from Patients with Chronic Pain. | Stensson N et al. | β | 2022 | β |
| Lipid endocannabinoids in energy metabolism, stress and developmental programming. | Almeida MM et al. | β | 2022 | β |
| Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. | Lian J et al. | β | 2022 | β |
| Natural Garlic Organosulfur Compounds Prevent Metabolic Disorder of Lipid and Glucose by Increasing Gut Commensal <i>Bacteroides acidifaciens</i>. | Chen K et al. | β | 2022 | β |
| N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics. | Chan JZ et al. | β | 2022 | β |
| Nuclear receptor ligand screening in an iPSC-derived <i>in vitro</i> blood-brain barrier model identifies new contributors to leptin transport | Shi Y et al. | β | 2022 | β |
| Nuclear receptor ligand screening in an iPSC-derived in vitro blood-brain barrier model identifies new contributors to leptin transport. | Shi Y et al. | β | 2022 | β |
| Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity. | Qin Y et al. | β | 2022 | β |
| Peroxisome Proliferator-Activated Receptor-Ξ±: A Pivotal Regulator of the Gastrointestinal Tract. | Guo YX et al. | β | 2022 | β |
| Profiling of fatty acid metabolism in the dorsal root ganglion after peripheral nerve injury. | Yamamoto S et al. | β | 2022 | β |
| Qualitative and Quantitative Analysis of Six Fatty Acid Amides in 11 Edible Vegetable Oils Using Liquid Chromatography-Mass Spectrometry. | Li Z et al. | β | 2022 | β |
| Selection-driven adaptation to the extreme Antarctic environment in the Emperor penguin. | Pirri F et al. | β | 2022 | β |
| Selective measurement of NAPE-PLD activity via a PLA<sub>1/2</sub>-resistant fluorogenic N-acyl-phosphatidylethanolamine analog. | Zarrow JE et al. | β | 2022 | β |
| Targeting the lysosome: Mechanisms and treatments for nonalcoholic fatty liver disease. | Pu J | β | 2022 | β |
| The endocannabinoid system in the adipose organ. | Jung KM et al. | β | 2022 | β |
| The Influence of the Differentiation of Genes Encoding Peroxisome Proliferator-Activated Receptors and Their Coactivators on Nutrient and Energy Metabolism. | Maciejewska-Skrendo A et al. | β | 2022 | β |
| The omega-3 hydroxy fatty acid 7(<i>S</i>)-HDHA is a high-affinity PPARΞ± ligand that regulates brain neuronal morphology. | Liu J et al. | β | 2022 | β |
| Accurate quantification of endogenous N-acylethanolamides by chemical isotope labeling coupled with liquid chromatography-tandem mass spectrometry. | Chen YQ et al. | β | 2021 | β |
| An abundant biliary metabolite derived from dietary omega-3 polyunsaturated fatty acids regulates triglycerides. | Grevengoed TJ et al. | β | 2021 | β |
| A sensitive LC-MS/MS method for the study of exogenously administered <sup>13</sup> C-oleoylethanolamide in rat plasma and brain tissue. | Prentice RN et al. | β | 2021 | β |
| Beneficial Effects of <i>Akkermansia muciniphila</i> Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARΞ± Agonists. | Depommier C et al. | β | 2021 | β |
| Beta-caryophyllene inhibits cocaineΒ addiction-related behavior by activation of PPARΞ± and PPARΞ³: repurposing a FDA-approved food additive for cocaine use disorder. | Galaj E et al. | β | 2021 | β |
| Brain histamine and oleoylethanolamide restore behavioral deficits induced by chronic social defeat stress in mice. | Rani B et al. | β | 2021 | β |
| Cannabidiol modulation of oxidative stress and signalling. | Pereira SR et al. | β | 2021 | β |
| Dietary excess regulates absorption and surface of gut epithelium through intestinal PPARΞ±. | StojanoviΔ O et al. | β | 2021 | β |
| Dietary lipids as regulators of reward processes: multimodal integration matters. | Berland C et al. | β | 2021 | β |
| Different roles for the acyl chain and the amine leaving group in the substrate selectivity of <i>N</i>-Acylethanolamine acid amidase. | Ghidini A et al. | β | 2021 | β |
| Endocannabinoids and related lipids in serum from patients with amyotrophic lateral sclerosis. | Carter GT et al. | β | 2021 | β |
| Endocannabinoids, endocannabinoid-like molecules and their precursors in human small intestinal lumen and plasma: does diet affect them? | Tagliamonte S et al. | β | 2021 | β |
| Expression of NF-ΞΊB, IL-6, and IL-10 genes, body composition, and hepatic fibrosis in obese patients with NAFLD-Combined effects of oleoylethanolamide supplementation and calorie restriction: A triple-blind randomized controlled clinical trial. | Tutunchi H et al. | β | 2021 | β |
| Fatty Acid Metabolism and Derived-Mediators Distinctive of PPAR-Ξ± Activation in Obese Subjects Post Bariatric Surgery. | Manca C et al. | β | 2021 | β |
| Genetic Blockade of NAAA Cell-specifically Regulates Fatty Acid Ethanolamides (FAEs) Metabolism and Inflammatory Responses. | Xie X et al. | β | 2021 | β |
| GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. | Manaithiya A et al. | β | 2021 | β |
| GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide. | Im DS | β | 2021 | β |
| High-fat but not normal-fat intake of extra virgin olive oil modulates the liver proteome of mice. | de Sousa IF et al. | β | 2021 | β |
| Host and microbiota metabolic signals in aging and longevity. | Zhou Y et al. | β | 2021 | β |
| Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients. | Pai AY et al. | β | 2021 | β |
| In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. | GonzΓ‘lez-Γlvarez H et al. | β | 2021 | β |
| Intuitive eating is associated with elevated levels of circulating omega-3-polyunsaturated fatty acid-derived endocannabinoidome mediators. | Rochefort G et al. | β | 2021 | β |
| Involvement of acid ceramidase in the degradation of bioactive N-acylethanolamines. | Tsuboi K et al. | β | 2021 | β |
| Joint reconstruction of cis-regulatory interaction networks across multiple tissues using single-cell chromatin accessibility data. | Dong K et al. | β | 2021 | β |
| Lipid metabolism and lipid signals in aging and longevity. | Mutlu AS et al. | β | 2021 | β |
| Lipid Signaling through G Proteins. | Cannon AE et al. | β | 2021 | β |
| N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats. | Fotio Y et al. | β | 2021 | β |
| Nuclear receptors NHR-49 and NHR-79 promote peroxisome proliferation to compensate for aldehyde dehydrogenase deficiency in C. elegans. | Zeng L et al. | β | 2021 | β |
| Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion. | Lu VB et al. | β | 2021 | β |
| Oleic acid and oleoylethanolamide decrease interferon-Ξ³-induced expression of PD-L1 and induce apoptosis in human lung carcinoma cells. | Yamagata K et al. | β | 2021 | β |
| Oleoylethanolamide Delays the Dysfunction and Death of Purkinje Cells and Ameliorates Behavioral Defects in a Mouse Model of Cerebellar Neurodegeneration. | PΓ©rez-MartΓn E et al. | β | 2021 | β |
| Palmitoleoylethanolamide Is an Efficient Anti-Obesity Endogenous Compound: Comparison with Oleylethanolamide in Diet-Induced Obesity. | Tovar R et al. | β | 2021 | β |
| Persistent proteomic changes in glutamatergic and GABAergic signaling in the amygdala of adolescent rats exposed to chlorpyrifos as juveniles. | Alugubelly N et al. | β | 2021 | β |
| Pharmacological Blockade of PPARΞ± Exacerbates Inflammatory Pain-Related Impairment of Spatial Memory in Rats. | Gaspar JC et al. | β | 2021 | β |
| Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System. | Lago-Fernandez A et al. | β | 2021 | β |
| Roles of Endocannabinoids and Endocannabinoid-Like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective. | Rahman SMK et al. | β | 2021 | β |
| Selective inhibition of monoacylglycerol lipase is associated with passive coping behavior and attenuation of stress-induced dopamine release in the medial prefrontal cortex. | PavΓ³n FJ et al. | β | 2021 | β |
| The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation. | Iannotti FA et al. | β | 2021 | β |
| The Role of PPAR Alpha in the Modulation of Innate Immunity. | Grabacka M et al. | β | 2021 | β |
| A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-Ξ±, on the management and prevention of obesity. | Tutunchi H et al. | β | 2020 | β |
| Beyond THC and Endocannabinoids. | Pacher P et al. | β | 2020 | β |
| Bile acid composition regulates GPR119-dependent intestinal lipid sensing and food intake regulation in mice. | Higuchi S et al. | β | 2020 | β |
| Biomarkers of appetite: is there a potential role for metabolomics? | Horner K et al. | β | 2020 | β |
| Cannabinoid CB<sub>1</sub> Receptors in the Intestinal Epithelium Are Required for Acute Western-Diet Preferences in Mice. | Avalos B et al. | β | 2020 | β |
| Chronic Effects of a High Sucrose Diet on Murine Gastrointestinal Nutrient Sensor Gene and Protein Expression Levels and Lipid Metabolism. | O'Brien P et al. | β | 2020 | β |
| Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARΞ± Activation. | Murru E et al. | β | 2020 | β |
| Development, validation and comparison of three LC-MS/MS methods for determination of endogenous striatal oleoyl ethanolamine in mice. | Guan Y et al. | β | 2020 | β |
| Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat. | Castonguay-Paradis S et al. | β | 2020 | β |
| Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice. | Mock ED et al. | β | 2020 | β |
| Druggable Targets in Endocannabinoid Signaling. | Gregus AM et al. | β | 2020 | β |
| Effects of oleoylethanolamide supplementation on atherogenic indices and hematological parameters in patients with nonalcoholic fatty liver disease: A clinical trial. | Tutunchi H et al. | β | 2020 | β |
| Enantioselective Synthesis of 7(<i>S</i>)-Hydroxydocosahexaenoic Acid, a Possible Endogenous Ligand for PPARΞ±. | Zhang M et al. | β | 2020 | β |
| Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction. | Sagheddu C et al. | β | 2020 | β |
| Engineering yeast phospholipid metabolism for de novo oleoylethanolamide production. | Liu Y et al. | β | 2020 | β |
| Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids. | Hermes DJ et al. | β | 2020 | β |
| First evidence on the role of palmitoylethanolamide in energy homeostasis in fish. | GΓ³mez-Boronat M et al. | β | 2020 | β |
| GPR119 Is a Potent Regulator of Human Sebocyte Biology. | Markovics A et al. | β | 2020 | β |
| Impact of intermittent voluntary ethanol consumption during adolescence on the expression of endocannabinoid system and neuroinflammatory mediators. | Sanchez-Marin L et al. | β | 2020 | β |
| Increased Anandamide and Decreased Pain and Depression after Exercise in Fibromyalgia. | Stensson N et al. | β | 2020 | β |
| Inhibition of fatty acid amide hydrolase by chlorpyrifos in juvenile rats results in altered exploratory and social behavior as adolescents. | Carr RL et al. | β | 2020 | β |
| Inhibition of fatty acid amide hydrolase in the CNS prevents and reverses morphine tolerance in male and female mice. | Fotio Y et al. | β | 2020 | β |
| Intestinal NAPE-PLD contributes to short-term regulation of food intake via gut-to-brain axis. | Rastelli M et al. | β | 2020 | β |
| Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis. | Dickens AM et al. | β | 2020 | β |
| Metabolic Profiling of Plasma in Different Calving Body Condition Score Cows Using an Untargeted Liquid Chromatography-Mass Spectrometry Metabolomics Approach. | Wang J et al. | β | 2020 | β |
| Molecular Mechanisms of Lysosome and Nucleus Communication. | Zhao Q et al. | β | 2020 | β |
| N-Acylphosphatidylethanolamines and N-acylethanolamines increase in saliva upon food mastication: the influence of the individual nutritional status and fat type in food. | De Luca L et al. | β | 2020 | β |
| Neuronal histamine and the memory of emotionally salient events. | Provensi G et al. | β | 2020 | β |
| Nuclear Hormone Receptors and Their Ligands: Metabolites in Control of Transcription. | Tao LJ et al. | β | 2020 | β |
| Oea Signaling Pathways and the Metabolic Benefits of Vertical Sleeve Gastrectomy. | Hutch CR et al. | β | 2020 | β |
| Oleic acid stimulates monoamine efflux through PPAR-Ξ±: Differential effects in diet-induced obesity. | Jagannathan L et al. | β | 2020 | β |
| Oleoylethanolamide Ameliorates Dextran Sulfate Sodium-Induced Colitis in Rats. | Otagiri S et al. | β | 2020 | β |
| Oleoylethanolamide decreases frustration stress-induced binge-like eating in female rats: a novel potential treatment for bingeΒ eating disorder. | Romano A et al. | β | 2020 | β |
| Oleoylethanolamide Exhibits GPR119-Dependent Inhibition of Osteoclast Function and GPR119-Independent Promotion of Osteoclast Apoptosis. | Kim HJ et al. | β | 2020 | β |
| Oleoylethanolamide Increases Glycogen Synthesis and Inhibits Hepatic Gluconeogenesis via the LKB1/AMPK Pathway in Type 2 Diabetic Model. | Ren T et al. | β | 2020 | β |
| Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice. | Hu J et al. | β | 2020 | β |
| Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-Ξ±, UCP1, and UCP2 genes. | Tutunchi H et al. | β | 2020 | β |
| Organelle Cooperation in Stem Cell Fate: Lysosomes as Emerging Regulators of Cell Identity. | Julian LM et al. | β | 2020 | β |
| Peroxisome Proliferator-Activated Receptors and Caloric Restriction-Common Pathways Affecting Metabolism, Health, and Longevity. | Duszka K et al. | β | 2020 | β |
| Peroxisome Proliferator-Activated Receptors as Molecular Links between Caloric Restriction and Circadian Rhythm. | Duszka K et al. | β | 2020 | β |
| Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases. | Decara J et al. | β | 2020 | β |
| Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone. | Gaspar JC et al. | β | 2020 | β |
| Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARΞ± dependent. | Azar S et al. | β | 2020 | β |
| Review: Control of feed intake by hepatic oxidation in ruminant animals: integration of homeostasis and homeorhesis. | Allen MS | β | 2020 | β |
| Structure-Activity Relationship Studies of Ξ±-Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family. | Zhou J et al. | β | 2020 | β |
| Symmetrically substituted dichlorophenes inhibit <i>N</i>-acyl-phosphatidylethanolamine phospholipase D. | Aggarwal G et al. | β | 2020 | β |
| Tetracosahexaenoylethanolamide, a novel <i>N</i>-acylethanolamide, is elevated in ischemia and increases neuronal output. | Lin L et al. | β | 2020 | β |
| The endocannabinoid system. | Kilaru A et al. | β | 2020 | β |
| Variability of <i>ACOX1</i> Gene Polymorphisms across Different Horse Breeds with Regard to Selection Pressure. | MyΔka G et al. | β | 2020 | β |
| Ξ²-Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents. | He Y et al. | β | 2020 | β |
| Acyl ethanolamides in Diabetes and Diabetic Nephropathy: Novel targets from untargeted plasma metabolomic profiles of South Asian Indian men. | Devi S et al. | β | 2019 | β |
| Administration of N-Acyl-Phosphatidylethanolamine Expressing Bacteria to Low Density Lipoprotein Receptor<sup>-/-</sup> Mice Improves Indices of Cardiometabolic Disease. | May-Zhang LS et al. | β | 2019 | β |
| Altered relationship between anandamide and glutamate in circulation after 30 min of arm cycling: A comparison of chronic pain subject with healthy controls. | Stensson N et al. | β | 2019 | β |
| Chronic oleoylethanolamide treatment attenuates diabetes-induced mice encephalopathy by triggering peroxisome proliferator-activated receptor alpha in the hippocampus. | Ren T et al. | β | 2019 | β |
| Dietary lipids with potential to affect satiety: Mechanisms and evidence. | Maher T et al. | β | 2019 | β |
| Diurnal Profiles of <i>N</i>-Acylethanolamines in Goldfish Brain and Gastrointestinal Tract: Possible Role of Feeding. | GΓ³mez-Boronat M et al. | β | 2019 | β |
| Effects of a High-Protein/Moderate-Carbohydrate Diet on Appetite, Gut Peptides, and Endocannabinoids-A Preview Study. | Tischmann L et al. | β | 2019 | β |
| Endocannabinoid regulation of homeostatic feeding and stress-induced alterations in food intake in male rats. | Sticht MA et al. | β | 2019 | β |
| Endocannabinoid system and the expression of endogenous ceramides in human hepatocellular carcinoma. | Yang J et al. | β | 2019 | β |
| Fatty Acid Metabolites as Novel Regulators of Non-shivering Thermogenesis. | Maurer SF et al. | β | 2019 | β |
| Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response. | Lutkewitte AJ et al. | β | 2019 | β |
| Hypothalamic Integration of the Endocrine Signaling Related to Food Intake. | Klockars A et al. | β | 2019 | β |
| Immunomodulatory effect of oleoylethanolamide in dendritic cells via TRPV1/AMPK activation. | Yao E et al. | β | 2019 | β |
| Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa. | Collu R et al. | β | 2019 | β |
| Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation. | Lacatusu I et al. | β | 2019 | β |
| <i>N</i>-acyl taurines are endogenous lipid messengers that improve glucose homeostasis. | Grevengoed TJ et al. | β | 2019 | β |
| Integration of phospholipid-complex nanocarrier assembly with endogenous N-oleoylethanolamine for efficient stroke therapy. | Yang X et al. | β | 2019 | β |
| Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. | Everard A et al. | β | 2019 | β |
| Investigation the effect of oleoylethanolamide supplementation on the abundance of Akkermansia muciniphila bacterium and the dietary intakes in people with obesity: A randomized clinical trial. | Payahoo L et al. | β | 2019 | β |
| Linking Lipid Metabolism to Chromatin Regulation in Aging. | Papsdorf K et al. | β | 2019 | β |
| Lipokines and Thermogenesis. | Lynes MD et al. | β | 2019 | β |
| Mast Cell-Derived Histamine Regulates Liver Ketogenesis via Oleoylethanolamide Signaling. | Misto A et al. | β | 2019 | β |
| Modulation of the Endocannabinoid System as a Potential Anticancer Strategy. | Ramer R et al. | β | 2019 | β |
| Multi-Staged Regulation of Lipid Signaling Mediators during Myogenesis by COX-1/2 Pathways. | Mo C et al. | β | 2019 | β |
| Non-endocannabinoid N-acylethanolamines and 2-monoacylglycerols in the intestine. | Hansen HS et al. | β | 2019 | β |
| Oleoylethanolamide: A novel pharmaceutical agent in the management of obesity-an updated review. | Laleh P et al. | β | 2019 | β |
| Oleoylethanolamide inhibits glial activation via moudulating PPARΞ± and promotes motor function recovery after brain ischemia. | Luo D et al. | β | 2019 | β |
| Phospholipid Remodeling in Physiology and Disease. | Wang B et al. | β | 2019 | β |
| Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants. | Romero-Sanchiz P et al. | β | 2019 | β |
| PPARs and pain. | Okine BN et al. | β | 2019 | β |
| Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS. | RΓΆhrig W et al. | β | 2019 | β |
| Recent Advances in the Neurobiology of Altered Motivation Following Bariatric Surgery. | Brutman JN et al. | β | 2019 | β |
| Relay of peripheral oxytocin to central oxytocin neurons via vagal afferents for regulating feeding. | Iwasaki Y et al. | β | 2019 | β |
| Silencing synaptic MicroRNA-411 reduces voluntary alcohol consumption in mice. | Most D et al. | β | 2019 | β |
| Simple nutrients bypass the requirement for HLH-30 in coupling lysosomal nutrient sensing to survival. | Murphy JT et al. | β | 2019 | β |
| The effects of oleoylethanolamide, an endogenous PPAR-Ξ± agonist, on risk factors for NAFLD: A systematic review. | Tutunchi H et al. | β | 2019 | β |
| Two-week administration of engineered Escherichia coli establishes persistent resistance to diet-induced obesity even without antibiotic pre-treatment. | Dosoky NS et al. | β | 2019 | β |
| An Analysis of Endocannabinoid Concentrations and Mood Following Singing and Exercise in Healthy Volunteers. | Stone NL et al. | β | 2018 | β |
| Basic mechanisms of the regulation of L-carnitine status in monogastrics and efficacy of L-carnitine as a feed additive in pigs and poultry. | Ringseis R et al. | β | 2018 | β |
| Central regulation of food intake in fish: an evolutionary perspective. | Soengas JL et al. | β | 2018 | β |
| Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? | Hillard CJ | β | 2018 | β |
| Dietary fatty acid composition impacts plasma fatty acid ethanolamide levels and body composition in golden Syrian hamsters. | Sihag J et al. | β | 2018 | β |
| Dietary fatty acids augment tissue levels of n-acylethanolamines in n-acylphosphatidylethanolamine phospholipase D (NAPE-PLD) knockout mice. | Lin L et al. | β | 2018 | β |
| Disruption of the gonadal endocannabinoid system in zebrafish exposed to diisononyl phthalate. | Forner-Piquer I et al. | β | 2018 | β |
| Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1. | Paternoster S et al. | β | 2018 | β |
| Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. | Danandeh A et al. | β | 2018 | β |
| Endocannabinoids and related <i>N</i>-acylethanolamines: biological activities and metabolism. | Tsuboi K et al. | β | 2018 | β |
| Endocannabinoids in Body Weight Control. | Horn H et al. | β | 2018 | β |
| Enteric Microbiotaβ»Gutβ»Brain Axis from the Perspective of Nuclear Receptors. | Duszka K et al. | β | 2018 | β |
| Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643. | Li G et al. | β | 2018 | β |
| Human Liver Fatty Acid Binding Protein-1 T94A Variant, Nonalcohol Fatty Liver Disease, and Hepatic Endocannabinoid System. | Martin GG et al. | β | 2018 | β |
| Impact of Dietary Fats on Brain Functions. | Chianese R et al. | β | 2018 | β |
| Is hepatic peroxisome proliferator-activated receptor Ξ± essential for the metabolic effects of fibrates? | Kamijo Y | β | 2018 | β |
| Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats. | Satta V et al. | β | 2018 | β |
| Metabolomic "Dark Matter" Dependent on Peroxisomal Ξ²-Oxidation in Caenorhabditis elegans. | Artyukhin AB et al. | β | 2018 | β |
| Metformin attenuates susceptibility to inflammation-induced preterm birth in mice with higher endocannabinoid levels. | Sun X et al. | β | 2018 | β |
| Molecular Imaging of the Cannabinoid System in Idiopathic Parkinson's Disease. | Cilia R | β | 2018 | β |
| n-3 polyunsaturated N-acylethanolamines are CB<sub>2</sub> cannabinoid receptor-preferring endocannabinoids. | Alharthi N et al. | β | 2018 | β |
| N-acylethanolamine hydrolyzing acid amidase inhibition: tools and potential therapeutic opportunities. | Bottemanne P et al. | β | 2018 | β |
| N-Docosahexaenoylethanolamine: A neurotrophic and neuroprotective metabolite of docosahexaenoic acid. | Kim HY et al. | β | 2018 | β |
| Oleoylethanolamide alleviates macrophage formation via AMPK/PPARΞ±/STAT3 pathway. | Zhao Y et al. | β | 2018 | β |
| Oleoylethanolamide and Palmitoylethanolamide Protect Cultured Cortical Neurons Against Hypoxia. | Portavella M et al. | β | 2018 | β |
| Oleoylethanolamide differentially regulates glycerolipid synthesis and lipoprotein secretion in intestine and liver. | Pan X et al. | β | 2018 | β |
| Oleoylethanolamide increases the expression of PPAR-Ξ and reduces appetite and body weight in obese people: A clinical trial. | Laleh P et al. | β | 2018 | β |
| Oleoylethanolamide-induced anorexia in rats is associated with locomotor impairment. | Fedele S et al. | β | 2018 | β |
| Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice. | Brown JD et al. | β | 2018 | β |
| Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse. | Orio L et al. | β | 2018 | β |
| Oleoylethanolamide Supplementation Reduces Inflammation and Oxidative Stress in Obese People: A Clinical Trial. | Payahoo L et al. | β | 2018 | β |
| Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour. | Sihag J et al. | β | 2018 | β |
| Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia. | Holubiec MI et al. | β | 2018 | β |
| Peripheral Endocannabinoids Associated With Energy Expenditure in Native Americans of Southwestern Heritage. | Heinitz S et al. | β | 2018 | β |
| Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion. | Little TJ et al. | β | 2018 | β |
| Role of Bisphenol A on the Endocannabinoid System at central and peripheral levels: Effects on adult female zebrafish. | Forner-Piquer I et al. | β | 2018 | β |
| Scp-2/Scp-x ablation in Fabp1 null mice differentially impacts hepatic endocannabinoid level depending on dietary fat. | Martin GG et al. | β | 2018 | β |
| Secretion, isotopic labeling and deglycosylation of N-acylethanolamine acid amidase for biophysical studies. | Pavlopoulos S et al. | β | 2018 | β |
| Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55. | Guerrero-Alba R et al. | β | 2018 | β |
| Targeting the endocannabinoid system as a potential anticancer approach. | Schwarz R et al. | β | 2018 | β |
| The N-Acylethanolamine Acid Amidase Inhibitor ARN077 Suppresses Inflammation and Pruritus in a Mouse Model of AllergicΒ Dermatitis. | Sasso O et al. | β | 2018 | β |
| Therapeutic application of GPR119 ligands in metabolic disorders. | Yang JW et al. | β | 2018 | β |
| The Relationship of Endocannabinoidome Lipid Mediators With Pain and Psychological Stress in Women With Fibromyalgia: A Case-Control Study. | Stensson N et al. | β | 2018 | β |
| The role of fatty acids and their endocannabinoid-like derivatives in the molecular regulation of appetite. | Witkamp RF | β | 2018 | β |
| Treatment of anorexia nervosa with palmitoylethanoamide. | Scolnick B | β | 2018 | β |
| Acylethanolamides and endocannabinoid signaling system in dorsal striatum of rats exposed to perinatal asphyxia. | Holubiec MI et al. | β | 2017 | β |
| Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study. | Stensson N et al. | β | 2017 | β |
| Association Between Plasma N-Acylethanolamides and High Hemoglobin Concentration in Southern Peruvian Highlanders. | AlarcΓ³n-Yaquetto DE et al. | β | 2017 | β |
| Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1. | Ratano P et al. | β | 2017 | β |
| Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors. | Irving A et al. | β | 2017 | β |
| Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini-Review. | Koch M | β | 2017 | β |
| Cannabinoids as Anticancer Drugs. | Ramer R et al. | β | 2017 | β |
| Commensal bacteria make GPCR ligands that mimic human signalling molecules. | Cohen LJ et al. | β | 2017 | β |
| Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. | Carr RL et al. | β | 2017 | β |
| Differential tissue regulation of peroxisome proliferator-activated receptor Ξ± (PPARΞ±) and cannabinoid receptor 1 (CB1) gene transcription pathways by diethylene glycol dibenzoate (DEGB): preliminary observations in a seabream (Sparus aurata) in vivo model. | Cocci P et al. | β | 2017 | β |
| Distinct but complementary contributions of PPAR isotypes to energy homeostasis. | Dubois V et al. | β | 2017 | β |
| Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome. | Igarashi M et al. | β | 2017 | β |
| Effects of Intermittent Alcohol Exposure on Emotion and Cognition: A Potential Role for the Endogenous Cannabinoid System and Neuroinflammation. | Sanchez-Marin L et al. | β | 2017 | β |
| Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men. | Kantae V et al. | β | 2017 | β |
| Gastric bypass surgery mimetic approaches. | Boettcher BR | β | 2017 | β |
| Gastric Bypass Surgery Recruits a Gut PPAR-Ξ±-Striatal D1R Pathway to Reduce Fat Appetite in Obese Rats. | Hankir MK et al. | β | 2017 | β |
| Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. | Yang JY et al. | β | 2017 | β |
| Histaminergic Neurotransmission as a Gateway for the Cognitive Effect of Oleoylethanolamide in Contextual Fear Conditioning. | Provensi G et al. | β | 2017 | β |
| Identification of a Widespread Palmitoylethanolamide Contamination in Standard Laboratory Glassware. | Angelini R et al. | β | 2017 | β |
| Inflammation of peripheral tissues and injury to peripheral nerves induce differing effects in the expression of the calcium-sensitive N-arachydonoylethanolamine-synthesizing enzyme and related molecules in rat primary sensory neurons. | Sousa-Valente J et al. | β | 2017 | β |
| Inhibition of Endocannabinoid-Metabolizing Enzymes in Peripheral Tissues Following Developmental Chlorpyrifos Exposure in Rats. | Buntyn RW et al. | β | 2017 | β |
| In vitro and in vivo pharmacology of NXT629, a novel and selective PPARΞ± antagonist. | Stebbins KJ et al. | β | 2017 | β |
| Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D. | Chen Z et al. | β | 2017 | β |
| Lipid signaling and fat storage in the dark-eyed junco. | Ho JM et al. | β | 2017 | β |
| Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response to a high-fat diet. | Martin GG et al. | β | 2017 | β |
| Mammalian enzymes responsible for the biosynthesis of N-acylethanolamines. | Hussain Z et al. | β | 2017 | β |
| Natural product discovery from the human microbiome. | Wilson MR et al. | β | 2017 | β |
| Nutrient-sensing nuclear receptors PPARΞ± and FXR control liver energy balance. | Preidis GA et al. | β | 2017 | β |
| Obesity: Current and potential pharmacotherapeutics and targets. | Narayanaswami V et al. | β | 2017 | β |
| Oleic acid-derived oleoylethanolamide: A nutritional science perspective. | Bowen KJ et al. | β | 2017 | β |
| Oleoylethanolamide: A fat ally in the fight against obesity. | Brown JD et al. | β | 2017 | β |
| Oleoylethanolamide inhibits Ξ±-melanocyte stimulating hormone-stimulated melanogenesis via ERK, Akt and CREB signaling pathways in B16 melanoma cells. | Zhou J et al. | β | 2017 | β |
| Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration. | AntΓ³n M et al. | β | 2017 | β |
| Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARΞ±. | Karwad MA et al. | β | 2017 | β |
| Peripheral tissue levels and molecular species compositions of N-acyl-phosphatidylethanolamine and its metabolites in mice lacking N-acyl-phosphatidylethanolamine-specific phospholipase D. | Inoue M et al. | β | 2017 | β |
| Peroxisome proliferator-activated receptor Ξ± ligands and modulators from dietary compounds: Types, screening methods and functions. | Yang H et al. | β | 2017 | β |
| Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence. | Garcia-Marchena N et al. | β | 2017 | β |
| PPAR-Ξ± acutely inhibits functional activity of ASICs in rat dorsal root ganglion neurons. | Wu J et al. | β | 2017 | β |
| Role of the area postrema in the hypophagic effects of oleoylethanolamide. | Romano A et al. | β | 2017 | β |
| Suppression of acute and anticipatory nausea by peripherally restricted fatty acid amide hydrolase inhibitor in animal models: role of PPARΞ± and CB<sub>1</sub> receptors. | Rock EM et al. | β | 2017 | β |
| Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome. | Tan CK et al. | β | 2017 | β |
| Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy. | Wortley MA et al. | β | 2017 | β |
| The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP-dependent vasorelaxant. | Al Suleimani YM et al. | β | 2017 | β |
| The hepatokine FGF21 is crucial for peroxisome proliferator-activated receptor-Ξ± agonist-induced amelioration of metabolic disorders in obese mice. | Goto T et al. | β | 2017 | β |
| The Importance of the Gastrointestinal Tract in Controlling Food Intake and Regulating Energy Balance. | Monteiro MP et al. | β | 2017 | β |
| The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol self-administration in rats. | Haile CN et al. | β | 2017 | β |
| The Role of Nuclear Hormone Receptors in Cannabinoid Function. | Pistis M et al. | β | 2017 | β |
| A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation. | Scarpelli R et al. | β | 2016 | β |
| An Important Role for N-Acylethanolamine Acid Amidase in the Complete Freund's Adjuvant Rat Model of Arthritis. | Bonezzi FT et al. | β | 2016 | β |
| An Introduction to the Endogenous Cannabinoid System. | Lu HC et al. | β | 2016 | β |
| Antitumorigenic targets of cannabinoids - current status and implications. | Ramer R et al. | β | 2016 | β |
| An update on PPAR activation by cannabinoids. | O'Sullivan SE | β | 2016 | β |
| A quantitative study on splice variants of N-acylethanolamine acid amidase in human prostate cancer cells and other cells. | Sakura Y et al. | β | 2016 | β |
| A role of CB1R in inducing ΞΈ-rhythm coordination between the gustatory and gastrointestinal insula. | Kang Y et al. | β | 2016 | β |
| Bile Acid Recognition by NAPE-PLD. | Margheritis E et al. | β | 2016 | β |
| Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7. | Rahman IA et al. | β | 2016 | β |
| Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics. | Julve J et al. | β | 2016 | β |
| Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. | Gamble-George JC et al. | β | 2016 | β |
| Detection and qualitative analysis of fatty acid amides in the urine of alcoholics using HPLC-QTOF-MS. | Dabur R et al. | β | 2016 | β |
| Dietary fatty acid composition affects food intake and gut-brain satiety signaling in Senegalese sole (Solea senegalensis, Kaup 1858) larvae and post-larvae. | Bonacic K et al. | β | 2016 | β |
| Eating disorders: from bench to bedside and back. | Gaetani S et al. | β | 2016 | β |
| Effects of canola and high-oleic-acid canola oils on abdominal fat mass in individuals with central obesity. | Liu X et al. | β | 2016 | β |
| Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders. | Iannotti FA et al. | β | 2016 | β |
| Endocannabinoids in the gastrointestinal tract. | Lee Y et al. | β | 2016 | β |
| Fatty acid amide supplementation decreases impulsivity in young adult heavy drinkers. | van Kooten MJ et al. | β | 2016 | β |
| Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias. | Schroeder F et al. | β | 2016 | β |
| Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration. | Herrera MI et al. | β | 2016 | β |
| GPR119: a promising target for nonalcoholic fatty liver disease. | Yang JW et al. | β | 2016 | β |
| High levels of endogenous lipid mediators (N-acylethanolamines) in women with chronic widespread pain during acute tissue trauma. | Stensson N et al. | β | 2016 | β |
| Identification and characterization of PPARΞ± ligands in the hippocampus. | Roy A et al. | β | 2016 | β |
| Incorporation of an Endogenous Neuromodulatory Lipid, Oleoylethanolamide, into Cubosomes: Nanostructural Characterization. | Younus M et al. | β | 2016 | β |
| Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition. | Pu S et al. | β | 2016 | β |
| Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet. | Wang B et al. | β | 2016 | β |
| Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells. | Hodge D et al. | β | 2016 | β |
| Macrophage-derived lipid agonists of PPAR-Ξ± as intrinsic controllers of inflammation. | Pontis S et al. | β | 2016 | β |
| Modeling Energy Dynamics in Mice with Skeletal Muscle Hypertrophy Fed High Calorie Diets. | Bond ND et al. | β | 2016 | β |
| Nanoparticles prolong N-palmitoylethanolamide anti-inflammatory and analgesic effects in vivo. | Tronino D et al. | β | 2016 | β |
| N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-Ξ±-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-Ξ±. | Xu X et al. | β | 2016 | β |
| Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARΞ± signaling and inhibiting the NF-ΞΊB and ERK1/2/AP-1/STAT3 pathways. | Yang L et al. | β | 2016 | β |
| Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor. | Hassing HA et al. | β | 2016 | β |
| Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-Ξ²1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis. | Orefice NS et al. | β | 2016 | β |
| Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl-2'-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. | Citraro R et al. | β | 2016 | β |
| Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies. | Migliore M et al. | β | 2016 | β |
| PPAR-Ξ± Agonist WY-14643 Inhibits LPS-Induced Inflammation in Synovial Fibroblasts via NF-kB Pathway. | Huang D et al. | β | 2016 | β |
| Role of the satiety factor oleoylethanolamide in alcoholism. | Bilbao A et al. | β | 2016 | β |
| The Macronutrients, Appetite, and Energy Intake. | Carreiro AL et al. | β | 2016 | β |
| Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat. | Jacome-Sosa M et al. | β | 2016 | β |
| Activity-Based Probe for N-Acylethanolamine Acid Amidase. | Romeo E et al. | β | 2015 | β |
| Aging. Lysosomal signaling molecules regulate longevity in Caenorhabditis elegans. | Folick A et al. | β | 2015 | β |
| A potential role for cannabinoid receptors in the therapeutic action of fenofibrate. | Priestley RS et al. | β | 2015 | β |
| A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation. | Ribeiro A et al. | β | 2015 | β |
| A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-Ξ± Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo. | Messmer D et al. | β | 2015 | β |
| Cell biology. Lysosomal lipid lengthens life span. | Han S et al. | β | 2015 | β |
| Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals? | Romano A et al. | β | 2015 | β |
| Effect of High Fat Diets on Body Mass, Oleylethanolamide Plasma Levels and Oxytocin Expression in Growing Rats. | Sospedra I et al. | β | 2015 | β |
| Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats. | Li L et al. | β | 2015 | β |
| Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats. | Piras A et al. | β | 2015 | β |
| Endocannabinoids and the Digestive Tract and Bladder in Health and Disease. | Izzo AA et al. | β | 2015 | β |
| Endocannabinoid signaling mediates oxytocin-driven social reward. | Wei D et al. | β | 2015 | β |
| Enhancing hepatic mitochondrial fatty acid oxidation stimulates eating in food-deprived mice. | Mansouri A et al. | β | 2015 | β |
| Fatty acid amide hydrolase inhibitors: a patent review (2009-2014). | Lodola A et al. | β | 2015 | β |
| Feeding-induced oleoylethanolamide mobilization is disrupted in the gut of diet-induced obese rodents. | Igarashi M et al. | β | 2015 | β |
| Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis. | Tsuboi K et al. | β | 2015 | β |
| Gut fat signaling and appetite control with special emphasis on the effect of thylakoids from spinach on eating behavior. | Rebello CJ et al. | β | 2015 | β |
| Hypocretin neuron-specific transcriptome profiling identifies the sleep modulator Kcnh4a. | Yelin-Bekerman L et al. | β | 2015 | β |
| Inhibition of FAAH confers increased stem cell migration via PPARΞ±. | Wollank Y et al. | β | 2015 | β |
| Inhibition of monoacylglycerol lipase reduces nicotine withdrawal. | Muldoon PP et al. | β | 2015 | β |
| Inhibitory effects of oleoylethanolamide (OEA) on HβOβ-induced human umbilical vein endothelial cell (HUVEC) injury and apolipoprotein E knockout (ApoE-/-) atherosclerotic mice. | Ma L et al. | β | 2015 | β |
| Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARΞ± and CB1 receptor mechanism, respectively: a double dissociation. | Rock EM et al. | β | 2015 | β |
| Intestinal lipid-derived signals that sense dietary fat. | DiPatrizio NV et al. | β | 2015 | β |
| Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways. | Chon SH et al. | β | 2015 | β |
| Lipid-mediated regulation of SKN-1/Nrf in response to germ cell absence. | Steinbaugh MJ et al. | β | 2015 | β |
| New insights into antimetastatic and antiangiogenic effects of cannabinoids. | Ramer R et al. | β | 2015 | β |
| Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice. | Wang H et al. | β | 2015 | β |
| Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation. | Fresno N et al. | β | 2015 | β |
| Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans. | Mennella I et al. | β | 2015 | β |
| Oleoylethanolamide, an endogenous PPAR-Ξ± ligand, attenuates liver fibrosis targeting hepatic stellate cells. | Chen L et al. | β | 2015 | β |
| O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors. | Colombano G et al. | β | 2015 | β |
| Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide/endocannabinoid signaling system associated to memory impairments in postweaned rats. | Blanco E et al. | β | 2015 | β |
| Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive. | Sasso O et al. | β | 2015 | β |
| Peroxisome proliferator-activated receptors Ξ± and Ξ³ are linked with alcohol consumption in mice and withdrawal and dependence in humans. | Blednov YA et al. | β | 2015 | β |
| Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context. | Rivera P et al. | β | 2015 | β |
| PPARΞ± signaling in the hippocampus: crosstalk between fat and memory. | Roy A et al. | β | 2015 | β |
| Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe. | Sun YN et al. | β | 2015 | β |
| Structure of human N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: regulation of fatty acid ethanolamide biosynthesis by bile acids. | Magotti P et al. | β | 2015 | β |
| Synthesis and evaluation of fatty acid amides on the N-oleoylethanolamide-like activation of peroxisome proliferator activated receptor Ξ±. | Takao K et al. | β | 2015 | β |
| The Endocannabinoid Signaling System in the CNS: A Primer. | Hillard CJ | β | 2015 | β |
| The L-Cell in Nutritional Sensing and the Regulation of Appetite. | Spreckley E et al. | β | 2015 | β |
| Acute resistance exercise induces antinociception by activation of the endocannabinoid system in rats. | Galdino G et al. | β | 2014 | β |
| Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms. | Yamashita A et al. | β | 2014 | β |
| Advances in the discovery of N-acylethanolamine acid amidase inhibitors. | Bandiera T et al. | β | 2014 | β |
| A lipid gate for the peripheral control of pain. | Piomelli D et al. | β | 2014 | β |
| Anandamide in primary sensory neurons: too much of a good thing? | Sousa-Valente J et al. | β | 2014 | β |
| A role for oleoylethanolamide in chronic lymphocytic leukemia. | Masoodi M et al. | β | 2014 | β |
| Atheroprotective effect of oleoylethanolamide (OEA) targeting oxidized LDL. | Fan A et al. | β | 2014 | β |
| Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training. | Bystrowska B et al. | β | 2014 | β |
| Characterization of duodenal expression and localization of fatty acid-sensing receptors in humans: relationships with body mass index. | Little TJ et al. | β | 2014 | β |
| Classical endocannabinoid-like compounds and their regulation by nutrients. | Kleberg K et al. | β | 2014 | β |
| Computational and biological evaluation of N-octadecyl-N'-propylsulfamide, a selective PPARΞ± agonist structurally related to N-acylethanolamines. | Moreno-Santos I et al. | β | 2014 | β |
| Dietary non-esterified oleic Acid decreases the jejunal levels of anorectic N-acylethanolamines. | Diep TA et al. | β | 2014 | β |
| Endocannabinoid signaling and its regulation by nutrients. | Bisogno T et al. | β | 2014 | β |
| Fat sensing and metabolic syndrome. | Youn JH | β | 2014 | β |
| Harnessing the anti-inflammatory potential of palmitoylethanolamide. | Alhouayek M et al. | β | 2014 | β |
| High dietary fat intake influences the activation of specific hindbrain and hypothalamic nuclei by the satiety factor oleoylethanolamide. | Romano A et al. | β | 2014 | β |
| Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity. | Chen Z et al. | β | 2014 | β |
| Integrated physiology and systems biology of PPARΞ±. | Kersten S | β | 2014 | β |
| Lipid metabolites as metabolic messengers in inter-organ communication. | Liu S et al. | β | 2014 | β |
| Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans. | Jones PJ et al. | β | 2014 | β |
| Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite. | Romano A et al. | β | 2014 | β |
| Oleoylethanolamide enhances Ξ²-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat. | SuΓ‘rez J et al. | β | 2014 | β |
| Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of ParkinsonΒ΄s disease. | GonzΓ‘lez-Aparicio R et al. | β | 2014 | β |
| Palmitoylethanolamide in CNS health and disease. | Mattace Raso G et al. | β | 2014 | β |
| Palmitoylethanolamide prevents metabolic alterations and restores leptin sensitivity in ovariectomized rats. | Mattace Raso G et al. | β | 2014 | β |
| Peripheral gating of pain signals by endogenous lipid mediators. | Piomelli D et al. | β | 2014 | β |
| Pharmacology of the capsaicin receptor, transient receptor potential vanilloid type-1 ion channel. | Nagy I et al. | β | 2014 | β |
| Physiological functions of peroxisome proliferator-activated receptor Ξ². | Neels JG et al. | β | 2014 | β |
| PPARs Integrate the Mammalian Clock and Energy Metabolism. | Chen L et al. | β | 2014 | β |
| PPARΞ±-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis. | Zhou X et al. | β | 2014 | β |
| Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat. | Hansen HS | β | 2014 | β |
| Role of oleoylethanolamide as a feeding regulator in goldfish. | Tinoco AB et al. | β | 2014 | β |
| Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury. | Esposito E et al. | β | 2014 | β |
| Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake. | Provensi G et al. | β | 2014 | β |
| Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. | Hermanson DJ et al. | β | 2014 | β |
| Systemic administration of oleoylethanolamide protects from neuroinflammation and anhedonia induced by LPS in rats. | Sayd A et al. | β | 2014 | β |
| Targeting the interaction between fatty acid ethanolamides and nicotinic receptors: therapeutic perspectives. | Melis M et al. | β | 2014 | β |
| Telmisartan increases lipoprotein lipase expression via peroxisome proliferator-activated receptor-alpha in HepG2 cells. | Yin SN et al. | β | 2014 | β |
| The effects of obesity, diabetes and metabolic syndrome on the hydrolytic enzymes of the endocannabinoid system in animal and human adipocytes. | Cable JC et al. | β | 2014 | β |
| The endocannabinoid system mediates aerobic exercise-induced antinociception in rats. | Galdino G et al. | β | 2014 | β |
| The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism. | Gonzalez-Aparicio R et al. | β | 2014 | β |
| Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide. | Azari EK et al. | β | 2014 | β |
| Adiponectin activates the AMPK signaling pathway to regulate lipid metabolism in bovine hepatocytes. | Chen H et al. | β | 2013 | β |
| A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. | Liu S et al. | β | 2013 | β |
| A fatty gut feeling. | Piomelli D | β | 2013 | β |
| A gut lipid messenger links excess dietary fat to dopamine deficiency. | Tellez LA et al. | β | 2013 | β |
| AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking. | Gamaleddin I et al. | β | 2013 | β |
| Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-Ξ± receptor activation in a genetic model of absence epilepsy. | Citraro R et al. | β | 2013 | β |
| Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models. | Sasso O et al. | β | 2013 | β |
| Cannabinoid receptors and cholecystokinin in feeding inhibition. | AlΓ©n F et al. | β | 2013 | β |
| Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. | Song R et al. | β | 2013 | β |
| Circadian clocks and metabolism. | Marcheva B et al. | β | 2013 | β |
| Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: influence on cholinergic toxicity. | Liu J et al. | β | 2013 | β |
| DHA attenuates postprandial hyperlipidemia via activating PPARΞ± in intestinal epithelial cells. | Kimura R et al. | β | 2013 | β |
| Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding. | Gajda AM et al. | β | 2013 | β |
| Endogenous cannabinoids revisited: a biochemistry perspective. | Fonseca BM et al. | β | 2013 | β |
| Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity. | PavΓ³n FJ et al. | β | 2013 | β |
| Fatty acid ethanolamides modulate CD36-mRNA through dietary fatty acid manipulation in Syrian Golden hamsters. | Lin L et al. | β | 2013 | β |
| Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism. | Naughton SS et al. | β | 2013 | β |
| GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function. | Odori S et al. | β | 2013 | β |
| Hedonic and homeostatic overlap following fat ingestion. | Begg DP et al. | β | 2013 | β |
| High-throughput screening for GPR119 modulators identifies a novel compound with anti-diabetic efficacy in db/db mice. | Zhang M et al. | β | 2013 | β |
| Hindbrain noradrenergic input to the hypothalamic PVN mediates the activation of oxytocinergic neurons induced by the satiety factor oleoylethanolamide. | Romano A et al. | β | 2013 | β |
| IL-6 cooperates with peroxisome proliferator-activated receptor-Ξ±-ligands to induce liver fatty acid binding protein (LFABP) up-regulation. | Vida M et al. | β | 2013 | β |
| Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction. | Panlilio LV et al. | β | 2013 | β |
| Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-Ξ± gene (PPARA) and schizophrenia. | Costa M et al. | β | 2013 | β |
| Involvement of phospholipase A/acyltransferase-1 in N-acylphosphatidylethanolamine generation. | Uyama T et al. | β | 2013 | β |
| Latest advances in the discovery of fatty acid amide hydrolase inhibitors. | Bisogno T et al. | β | 2013 | β |
| Lipidomic mass spectrometry and its application in neuroscience. | Enriquez-Algeciras M et al. | β | 2013 | β |
| Mechanisms of vasorelaxation induced by oleoylethanolamide in the rat small mesenteric artery. | AlSuleimani YM et al. | β | 2013 | β |
| Novel acylethanolamide derivatives that modulate body weight through enhancement of hypothalamic pro-opiomelanocortin (POMC) and/or decreased neuropeptide Y (NPY). | Avraham Y et al. | β | 2013 | β |
| Oleoylethanolamide dose-dependently attenuates cocaine-induced behaviours through a PPARΞ± receptor-independent mechanism. | Bilbao A et al. | β | 2013 | β |
| Oral administration of omega-7 palmitoleic acid induces satiety and the release of appetite-related hormones in male rats. | Yang ZH et al. | β | 2013 | β |
| Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. | Scherma M et al. | β | 2013 | β |
| Possible role of intestinal fatty acid oxidation in the eating-inhibitory effect of the PPAR-Ξ± agonist Wy-14643 in high-fat diet fed rats. | Karimian Azari E et al. | β | 2013 | β |
| PPARΞ± regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving Ξ±7 nicotinic acetylcholine receptors. | Melis M et al. | β | 2013 | β |
| Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR-Ξ΄ agonism correlates with impaired NLRP3 inflammasome activation. | Collino M et al. | β | 2013 | β |
| Temporal changes in N-acylethanolamine content and metabolism throughout the peri-adolescent period. | Lee TT et al. | β | 2013 | β |
| The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence. | Muldoon PP et al. | β | 2013 | β |
| The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons. | Romano A et al. | β | 2013 | β |
| The volitional nature of nicotine exposure alters anandamide and oleoylethanolamide levels in the ventral tegmental area. | Buczynski MW et al. | β | 2013 | β |
| 5, 8, 11, 14-eicosatetraynoic acid suppresses CCL2/MCP-1 expression in IFN-Ξ³-stimulated astrocytes by increasing MAPK phosphatase-1 mRNA stability. | Lee JH et al. | β | 2012 | β |
| A metabolic-transcriptional network links sleep and cellular energetics in the brain. | Wisor JP | β | 2012 | β |
| Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. | Luchicchi A et al. | β | 2012 | β |
| Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats. | Alonso M et al. | β | 2012 | β |
| A thickening network of lipids. | Piomelli D | β | 2012 | β |
| Control of food intake by metabolism of fuels: a comparison across species. | Allen MS et al. | β | 2012 | β |
| Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice. | Newberry EP et al. | β | 2012 | β |
| Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration. | Reyes-Cabello C et al. | β | 2012 | β |
| Elaidyl-sulfamide, an oleoylethanolamide-modelled PPARΞ± agonist, reduces body weight gain and plasma cholesterol in rats. | Decara JM et al. | β | 2012 | β |
| Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA). | Tai T et al. | β | 2012 | β |
| Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism. | Brown WH et al. | β | 2012 | β |
| Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors. | Kaczocha M et al. | β | 2012 | β |
| Function and Regulation of Lipid Biology in Caenorhabditis elegans Aging. | Hou NS et al. | β | 2012 | β |
| Generation of N-acylphosphatidylethanolamine by members of the phospholipase A/acyltransferase (PLA/AT) family. | Uyama T et al. | β | 2012 | β |
| Glibenclamide-pregnenolone derivative has greater hypoglycemic effects and biodistribution than glibenclamide-OH in alloxan-rats. | Figueroa-Valverde L et al. | β | 2012 | β |
| G-protein-coupled receptors in intestinal chemosensation. | Reimann F et al. | β | 2012 | β |
| Hub and switches: endocannabinoid signalling in midbrain dopamine neurons. | Melis M et al. | β | 2012 | β |
| Intestinal fatty acid infusion modulates food preference as well as calorie intake via the vagal nerve and midbrain-hypothalamic neural pathways in rats. | Ogawa N et al. | β | 2012 | β |
| Intestinal sensing of nutrients. | Tolhurst G et al. | β | 2012 | β |
| Link between intestinal CD36 ligand binding and satiety induced by a high protein diet in mice. | Naville D et al. | β | 2012 | β |
| Lipophilic amines as potent inhibitors of N-acylethanolamine-hydrolyzing acid amidase. | Yamano Y et al. | β | 2012 | β |
| Mechanisms of gene regulation by fatty acids. | Georgiadi A et al. | β | 2012 | β |
| Moving beyond "good fat, bad fat": the complex roles of dietary lipids in cellular function and health: session abstracts. | Abumrad NA et al. | β | 2012 | β |
| N-(2-oxo-3-oxetanyl)carbamic acid esters as N-acylethanolamine acid amidase inhibitors: synthesis and structure-activity and structure-property relationships. | Duranti A et al. | β | 2012 | β |
| Nerveless and gutsy: intestinal nutrient sensing from invertebrates to humans. | Miguel-Aliaga I | β | 2012 | β |
| New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury. | Neher MD et al. | β | 2012 | β |
| Nutrient sensing and the circadian clock. | Peek CB et al. | β | 2012 | β |
| Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acylethanolamines (NAE). | Coulon D et al. | β | 2012 | β |
| Oleamide activates peroxisome proliferator-activated receptor gamma (PPARΞ³) in vitro. | Dionisi M et al. | β | 2012 | β |
| Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor Ξ±. | Zhou Y et al. | β | 2012 | β |
| Palmitoylethanolamide protects against the amyloid-Ξ²25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease. | D'Agostino G et al. | β | 2012 | β |
| Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions. | Sasso O et al. | β | 2012 | β |
| Peripheral neural targets in obesity. | Page AJ et al. | β | 2012 | β |
| Peroxisome proliferator-activated receptor Ξ± mediates acute effects of palmitoylethanolamide on sensory neurons. | Khasabova IA et al. | β | 2012 | β |
| Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of Schizophrenia. | DesfossΓ©s J et al. | β | 2012 | β |
| PPARΞ± as a therapeutic target in inflammation-associated diseases. | Gervois P et al. | β | 2012 | β |
| Quantitative analysis of multiple fatty acid ethanolamides using ultra-performance liquid chromatography-tandem mass spectrometry. | Lin L et al. | β | 2012 | β |
| "Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control. | Piscitelli F et al. | β | 2012 | β |
| Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections. | Kallendrusch S et al. | β | 2012 | β |
| Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. | Pirat C et al. | β | 2012 | β |
| The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. | Scherma M et al. | β | 2012 | β |
| The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes. | Ha CY et al. | β | 2012 | β |
| The effect of a dietary supplement (N-oleyl-phosphatidyl-ethanolamine and epigallocatechin gallate) on dietary compliance and body fat loss in adults who are overweight: a double-blind, randomized control trial. | Mangine GT et al. | β | 2012 | β |
| The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity. | Heyman E et al. | β | 2012 | β |
| Ulcerative colitis impairs the acylethanolamide-based anti-inflammatory system reversal by 5-aminosalicylic acid and glucocorticoids. | SuΓ‘rez J et al. | β | 2012 | β |
| Unsaturated fatty alcohol derivatives of olive oil phenolic compounds with potential low-density lipoprotein (LDL) antioxidant and antiobesity properties. | Cotrim BA et al. | β | 2012 | β |
| Update on the role of cannabinoid receptors after ischemic stroke. | Capettini LS et al. | β | 2012 | β |
| Vagus nerve stimulation reduces body weight and fat mass in rats. | Banni S et al. | β | 2012 | β |
| Ξ²-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine. | Armirotti A et al. | β | 2012 | β |
| Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. | Goto T et al. | β | 2011 | β |
| Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. | Murillo-RodrΓguez E et al. | β | 2011 | β |
| Ageing in worms: N-acylethanolamines take control. | Shen R | β | 2011 | β |
| Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability. | Vacondio F et al. | β | 2011 | β |
| Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. | Mascia P et al. | β | 2011 | β |
| Cell signalling: why fasting worms age slowly. | De Petrocellis L et al. | β | 2011 | β |
| Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons. | Lueneberg K et al. | β | 2011 | β |
| Central and peripheral endocannabinoids and cognate acylethanolamides in humans: association with race, adiposity, and energy expenditure. | Jumpertz R et al. | β | 2011 | β |
| Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices. | Sarmad S et al. | β | 2011 | β |
| Development of a new class of benzoylpyrrole-based PPARΞ±/Ξ³ activators. | Ushiroda K et al. | β | 2011 | β |
| Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. | Diep TA et al. | β | 2011 | β |
| Dietary fat sensing via fatty acid oxidation in enterocytes: possible role in the control of eating. | Langhans W et al. | β | 2011 | β |
| Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control. | Semple G et al. | β | 2011 | β |
| Discovery of Potent Dual PPARΞ± Agonists/CB1 Ligands. | PΓ©rez-FernΓ‘ndez R et al. | β | 2011 | β |
| Effects of dietary fat on appetite and energy intake in health and obesity--oral and gastrointestinal sensory contributions. | Little TJ et al. | β | 2011 | β |
| Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects. | Marco EM et al. | β | 2011 | β |
| [Enzymes involved in the degradation of N-acylethanolamines functioning as lipid mediators]. | Tsuboi K et al. | β | 2011 | β |
| Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARΞ±-dependent and -independent pathways. | Goto T et al. | β | 2011 | β |
| High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women. | Ghafouri N et al. | β | 2011 | β |
| Inhibition of TNFΞ±-induced adhesion molecule expression by (Z)-(S)-9-octadecenamide, N-(2-hydroxyethyl,1-methyl). | Chen C et al. | β | 2011 | β |
| Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice. | Thabuis C et al. | β | 2011 | β |
| Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. | Lodhi IJ et al. | β | 2011 | β |
| Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. | Deblon N et al. | β | 2011 | β |
| Oleoylethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake. | Serrano A et al. | β | 2011 | β |
| Palmitoylethanolamide effects on intraocular pressure after Nd:YAG laser iridotomy: an experimental clinical study. | Pescosolido N et al. | β | 2011 | β |
| PPARΞ± agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes. | Nan WQ et al. | β | 2011 | β |
| Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas. | Li C et al. | β | 2011 | β |
| Stimulating beta cell replication and improving islet graft function by GPR119 agonists. | Gao J et al. | β | 2011 | β |
| Sympathetic activity controls fat-induced oleoylethanolamide signaling in small intestine. | Fu J et al. | β | 2011 | β |
| Synthesis and pharmacological evaluation of novel benzoylazole-based PPAR Ξ±/Ξ³ activators. | Ushiroda K et al. | β | 2011 | β |
| The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction. | Viveros MP et al. | β | 2011 | β |
| The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury. | Miglio G et al. | β | 2011 | β |
| Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2. | Lewis DY et al. | β | 2010 | β |
| An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis. | LorΓa F et al. | β | 2010 | β |
| A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase. | Gattinoni S et al. | β | 2010 | β |
| Basal and fasting/refeeding-regulated tissue levels of endogenous PPAR-alpha ligands in Zucker rats. | Izzo AA et al. | β | 2010 | β |
| Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. | O'Sullivan SE et al. | β | 2010 | β |
| Cannabinoids and the gut: new developments and emerging concepts. | Izzo AA et al. | β | 2010 | β |
| CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice. | Guijarro A et al. | β | 2010 | β |
| Cevoglitazar, a novel peroxisome proliferator-activated receptor-alpha/gamma dual agonist, potently reduces food intake and body weight in obese mice and cynomolgus monkeys. | Chen H et al. | β | 2010 | β |
| Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia. | Garami A et al. | β | 2010 | β |
| Deficits in gastrointestinal responses controlling food intake and body weight. | Covasa M | β | 2010 | β |
| Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats. | Wang H et al. | β | 2010 | β |
| Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-alpha nuclear receptors. | Luchicchi A et al. | β | 2010 | β |
| Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice. | Plaza-Zabala A et al. | β | 2010 | β |
| Endogenous ligands for nuclear receptors: digging deeper. | Schupp M et al. | β | 2010 | β |
| Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. | Gattinoni S et al. | β | 2010 | β |
| Enzymological studies on the biosynthesis of N-acylethanolamines. | Ueda N et al. | β | 2010 | β |
| FAAH deficiency promotes energy storage and enhances the motivation for food. | TouriΓ±o C et al. | β | 2010 | β |
| Fatty acid amide signaling molecules. | Ezzili C et al. | β | 2010 | β |
| GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. | Shah U et al. | β | 2010 | β |
| International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CBβ and CBβ. | Pertwee RG et al. | β | 2010 | β |
| In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability. | Giuffrida A et al. | β | 2010 | β |
| [Lipid nutrition and the epidermal barrier: The connection between immune-mediated inflammatory diseases and peroxisome proliferator-activated receptors, a new therapeutic target in psoriasis and atopic dermatitis]. | Villarrubia VG et al. | β | 2010 | β |
| Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice. | Perreault M et al. | β | 2010 | β |
| N-acylethanolamine metabolism with special reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). | Ueda N et al. | β | 2010 | β |
| N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. | Chu ZL et al. | β | 2010 | β |
| Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels. | De Petrocellis L et al. | β | 2010 | β |
| Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. | Smoum R et al. | β | 2010 | β |
| Oral and gastrointestinal sensing of dietary fat and appetite regulation in humans: modification by diet and obesity. | Little TJ et al. | β | 2010 | β |
| Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. | Hansen HS | β | 2010 | β |
| Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors. | Melis M et al. | β | 2010 | β |
| PPARs in Rhythmic Metabolic Regulation and Implications in Health and Disease. | Charoensuksai P et al. | β | 2010 | β |
| Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors. | Deng H | β | 2010 | β |
| Simultaneous measurement of three N-acylethanolamides in human bio-matrices using ultra performance liquid chromatography-tandem mass spectrometry. | Lam PM et al. | β | 2010 | β |
| Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors. | Onnis V et al. | β | 2010 | β |
| Synthesis of fatty acid amides of catechol metabolites that exhibit antiobesity properties. | Almeida B et al. | β | 2010 | β |
| The endocannabinoid system: its roles in energy balance and potential as a target for obesity treatment. | AndrΓ© A et al. | β | 2010 | β |
| The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin. | Gaetani S et al. | β | 2010 | β |
| The role of the autonomic nervous liver innervation in the control of energy metabolism. | Yi CX et al. | β | 2010 | β |
| Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma. | Jian W et al. | β | 2010 | β |
| Vasorelaxation to N-oleoylethanolamine in rat isolated arteries: mechanisms of action and modulation via cyclooxygenase activity. | Wheal AJ et al. | β | 2010 | β |
| Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial. | Rondanelli M et al. | β | 2009 | β |
| An introduction to the endocannabinoid system: from the early to the latest concepts. | De Petrocellis L et al. | β | 2009 | β |
| A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo. | Clapper JR et al. | β | 2009 | β |
| Biology of endocannabinoid synthesis system. | Wang J et al. | β | 2009 | β |
| Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. | D'Agostino G et al. | β | 2009 | β |
| Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. | Hill MN et al. | β | 2009 | β |
| Curcumin is not a ligand for peroxisome proliferator-activated receptor-Ξ³ | Narala VR et al. | β | 2009 | β |
| Dietary supplementation of tetradecylthioacetic acid increases feed intake but reduces body weight gain and adipose depot sizes in rats fed on high-fat diets. | Wensaas AJ et al. | β | 2009 | β |
| Discovery and characterization of an Arabidopsis thaliana N-acylphosphatidylethanolamine synthase. | Faure L et al. | β | 2009 | β |
| Effect of shanzha, a Chinese herbal product, on obesity and dyslipidemia in hamsters receiving high-fat diet. | Kuo DH et al. | β | 2009 | β |
| Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization. | Palandra J et al. | β | 2009 | β |
| Enhancement of PPAR-beta activity by repetitive low-grade H(2)O(2) stress protects human umbilical vein endothelial cells from subsequent oxidative stress-induced apoptosis. | Jiang B et al. | β | 2009 | β |
| Fat-induced satiety factor oleoylethanolamide enhances memory consolidation. | Campolongo P et al. | β | 2009 | β |
| Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. | Mazzola C et al. | β | 2009 | β |
| Genetic manipulation of palmitoylethanolamide production and inactivation in Saccharomyces cerevisiae. | Muccioli GG et al. | β | 2009 | β |
| GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. | Lauffer LM et al. | β | 2009 | β |
| Identification of intracellular carriers for the endocannabinoid anandamide. | Kaczocha M et al. | β | 2009 | β |
| Inhibitory effect of N-palmitoylphosphatidylethanolamine on macrophage phagocytosis through inhibition of Rac1 and Cdc42. | Shiratsuchi A et al. | β | 2009 | β |
| Intestinal lipids as signaling molecules. | Ahima RS | β | 2009 | β |
| Lipidomic analysis of endocannabinoid metabolism in biological samples. | Astarita G et al. | β | 2009 | β |
| Lipids as targets for novel anti-inflammatory therapies. | Huwiler A et al. | β | 2009 | β |
| Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo. | Kane CD et al. | β | 2009 | β |
| N-acylethanolamines, anandamide and food intake. | Hansen HS et al. | β | 2009 | β |
| Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells. | MartΓnez de Ubago M et al. | β | 2009 | β |
| Oleoylethanolamide exerts partial and dose-dependent neuroprotection of substantia nigra dopamine neurons. | Galan-Rodriguez B et al. | β | 2009 | β |
| Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases. | Pillarisetti S et al. | β | 2009 | β |
| Pharmacotherapy of obesity: emerging drugs and targets. | Chakrabarti R | β | 2009 | β |
| PPAR and Pain. | Maeda T et al. | β | 2009 | β |
| Rapid pain modulation with nuclear receptor ligands. | Fehrenbacher JC et al. | β | 2009 | β |
| Receptors for acylethanolamides-GPR55 and GPR119. | Godlewski G et al. | β | 2009 | β |
| Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance. | Borrelli F et al. | β | 2009 | β |
| Role of PPAR-beta in hydrogen peroxide-induced apoptosis in human umbilical vein endothelial cells. | Jiang B et al. | β | 2009 | β |
| Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. | Solorzano C et al. | β | 2009 | β |
| Signal transduction via cannabinoid receptors. | Dalton GD et al. | β | 2009 | β |
| Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid. | Koethe D et al. | β | 2009 | β |
| Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability. | Vacondio F et al. | β | 2009 | β |
| Synthesis and evaluation of novel alpha-heteroaryl-phenylpropanoic acid derivatives as PPARalpha/gamma dual agonists. | Casimiro-Garcia A et al. | β | 2009 | β |
| Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide. | Cano C et al. | β | 2009 | β |
| Targeted lipidomics as a tool to investigate endocannabinoid function. | Astarita G et al. | β | 2009 | β |
| The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs. | Gaetani S et al. | β | 2009 | β |
| The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice. | Cluny NL et al. | β | 2009 | β |
| The role of the endocannabinoid system in lipogenesis and fatty acid metabolism. | Vettor R et al. | β | 2009 | β |
| Time-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARΞ³). | O'Sullivan SE et al. | β | 2009 | β |
| Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase. | Wang J et al. | β | 2008 | β |
| Analysis of chemically synthesized oleoylethanolamide by gas-liquid chromatography. | Thabuis C et al. | β | 2008 | β |
| An optimized GC-MS method detects nanomolar amounts of anandamide in mouse brain. | Muccioli GG et al. | β | 2008 | β |
| Antiobesity designed multiple ligands: Synthesis of pyrazole fatty acid amides and evaluation as hypophagic agents. | Alvarado M et al. | β | 2008 | β |
| A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release. | Chu ZL et al. | β | 2008 | β |
| Biological functions and metabolism of oleoylethanolamide. | Thabuis C et al. | β | 2008 | β |
| Biosynthesis, degradation and pharmacological importance of the fatty acid amides. | Farrell EK et al. | β | 2008 | β |
| CB(1) receptor antagonism: biological basis for metabolic effects. | Di Marzo V | β | 2008 | β |
| Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats. | PavΓ³n FJ et al. | β | 2008 | β |
| Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. | Burdyga G et al. | β | 2008 | β |
| Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119. | Semple G et al. | β | 2008 | β |
| Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue. | Toyoda T et al. | β | 2008 | β |
| Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARalpha/gamma dual agonists, and X-ray crystallographic studies. | Casimiro-Garcia A et al. | β | 2008 | β |
| Endocannabinoids, adipose tissue and lipid metabolism. | Pagano C et al. | β | 2008 | β |
| Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. | Ning Y et al. | β | 2008 | β |
| Endogenous cannabinoids in patients with schizophrenia and substance use disorder during quetiapine therapy. | Potvin S et al. | β | 2008 | β |
| Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors. | Melis M et al. | β | 2008 | β |
| 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors. | Ho WS et al. | β | 2008 | β |
| Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. | Justinova Z et al. | β | 2008 | β |
| Gastrointestinal regulation of food intake: general aspects and focus on anandamide and oleoylethanolamide. | Capasso R et al. | β | 2008 | β |
| GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity. | Fyfe MC et al. | β | 2008 | β |
| GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity. | Overton HA et al. | β | 2008 | β |
| Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei. | SuΓ‘rez J et al. | β | 2008 | β |
| Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. | Artmann A et al. | β | 2008 | β |
| Inhibitory effect of the anorexic compound oleoylethanolamide on gastric emptying in control and overweight mice. | Aviello G et al. | β | 2008 | β |
| N-acylphosphatidylethanolamine, a gut- derived circulating factor induced by fat ingestion, inhibits food intake. | Gillum MP et al. | β | 2008 | β |
| No effect of an oleoylethanolamide-related phospholipid on satiety and energy intake: a randomised controlled trial of phosphatidylethanolamine. | Lithander FE et al. | β | 2008 | β |
| Peroxisome proliferator-activated receptor alpha and the ketogenic diet. | Cullingford T | β | 2008 | β |
| PPAR-alpha L162V and PGC-1 G482S gene polymorphisms, but not PPAR-gamma P12A, are associated with alcohol consumption in a Spanish Mediterranean population. | FrancΓ¨s F et al. | β | 2008 | β |
| PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression. | de Vogel-van den Bosch HM et al. | β | 2008 | β |
| PPARdelta Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities. | Perreault M et al. | β | 2008 | β |
| Role of the endocannabinoid system in metabolic control. | Wang J et al. | β | 2008 | β |
| Synthesis and quantitative structure-activity relationship of fatty acid amide hydrolase inhibitors: modulation at the N-portion of biphenyl-3-yl alkylcarbamates. | Mor M et al. | β | 2008 | β |
| Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. | Fu J et al. | β | 2008 | β |
| The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats. | Serrano A et al. | β | 2008 | β |
| The lipid messenger OEA links dietary fat intake to satiety. | Schwartz GJ et al. | β | 2008 | β |
| The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation. | Liang P et al. | β | 2008 | β |
| The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD). | Wang J et al. | β | 2008 | β |
| Transcriptional regulation of hepatic fatty acid metabolism. | Guillou H et al. | β | 2008 | β |
| Analgesic properties of oleoylethanolamide (OEA) in visceral and inflammatory pain. | SuardΓaz M et al. | β | 2007 | β |
| A neuroscientist's guide to lipidomics. | Piomelli D et al. | β | 2007 | β |
| A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. | Chu ZL et al. | β | 2007 | β |
| Biosynthetic pathways of the endocannabinoid anandamide. | Okamoto Y et al. | β | 2007 | β |
| Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. | Chakravarthy MV et al. | β | 2007 | β |
| Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. | Sun Y et al. | β | 2007 | β |
| Cannabinoids: a new group of agonists of PPARs. | Sun Y et al. | β | 2007 | β |
| Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. | O'Sullivan SE | β | 2007 | β |
| Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. | Degn M et al. | β | 2007 | β |
| Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. | Gervois P et al. | β | 2007 | β |
| Effects of clofibrate treatment in laying hens. | KΓΆnig B et al. | β | 2007 | β |
| Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. | Murillo-RodrΓguez E et al. | β | 2007 | β |
| Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. | Di Marzo V et al. | β | 2007 | β |
| Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players. | Lambert DM et al. | β | 2007 | β |
| Endocannabinoid system and pathophysiology of adipogenesis: current management of obesity. | Iqbal O | β | 2007 | β |
| Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats. | Marco EM et al. | β | 2007 | β |
| Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. | Fu J et al. | β | 2007 | β |
| Identification of endocannabinoids and related compounds in human fat cells. | Gonthier MP et al. | β | 2007 | β |
| Interaction of ligands for the peroxisome proliferator-activated receptor gamma with the endocannabinoid system. | Lenman A et al. | β | 2007 | β |
| Mechanism of oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction. | Yang Y et al. | β | 2007 | β |
| Metabolic Functions of Peroxisome Proliferator-Activated Receptor beta/delta in Skeletal Muscle. | Gaudel C et al. | β | 2007 | β |
| Novel cannabinoid receptors. | Brown AJ | β | 2007 | β |
| Nuclear receptors, metabolism, and the circadian clock. | Yang X et al. | β | 2007 | β |
| Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil. | Soriguer F et al. | β | 2007 | β |
| Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons. | Bento-Abreu A et al. | β | 2007 | β |
| Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies. | Tsuboi K et al. | β | 2007 | β |
| Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. | Matias I et al. | β | 2007 | β |
| The complications of promiscuity: endocannabinoid action and metabolism. | Alexander SP et al. | β | 2007 | β |
| The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. | Pagano C et al. | β | 2007 | β |
| The N-acylethanolamine-hydrolyzing acid amidase (NAAA). | Tsuboi K et al. | β | 2007 | β |
| The pharmacology of the cannabinoid system--a question of efficacy and selectivity. | Fowler CJ | β | 2007 | β |
| Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. | Yoon MJ et al. | β | 2006 | β |
| Association of peroxisome proliferator-activated receptor delta +294T/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. | Aberle J et al. | β | 2006 | β |
| Cannabinoid receptors as therapeutic targets. | Mackie K | β | 2006 | β |
| Cannabinoids and PPARalpha signalling. | Sun Y et al. | β | 2006 | β |
| Cold exposure stimulates synthesis of the bioactive lipid oleoylethanolamide in rat adipose tissue. | LoVerme J et al. | β | 2006 | β |
| Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. | Overton HA et al. | β | 2006 | β |
| Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. | Murillo-Rodriguez E et al. | β | 2006 | β |
| Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. | O'Sullivan SE et al. | β | 2006 | β |
| Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors. | Petersen G et al. | β | 2006 | β |
| Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. | Hallman DM et al. | β | 2006 | β |
| Movin' on up: adipocytes become regulators of nutrient homeostasis. | Unger RH et al. | β | 2006 | β |
| Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo. | Powell DR | β | 2006 | β |
| Pharmacological characterization of hydrolysis-resistant analogs of oleoylethanolamide with potent anorexiant properties. | Astarita G et al. | β | 2006 | β |
| Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. | Patel S et al. | β | 2006 | β |
| Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). | Piomelli D et al. | β | 2006 | β |
| Postprandial increase of oleoylethanolamide mobilization in small intestine of the Burmese python (Python molurus). | Astarita G et al. | β | 2006 | β |
| Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. | LoVerme J et al. | β | 2006 | β |
| Regulation of inflammation by PPARs: a future approach to treat lung inflammatory diseases? | Becker J et al. | β | 2006 | β |
| Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. | LΓ³pez-Soriano J et al. | β | 2006 | β |
| Selective PPAR agonists for the treatment of type 2 diabetes. | Nehlin JO et al. | β | 2006 | β |
| Signals from intra-abdominal fat modulate insulin and leptin sensitivity through different mechanisms: neuronal involvement in food-intake regulation. | Yamada T et al. | β | 2006 | β |
| Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. | Lefebvre P et al. | β | 2006 | β |
| Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? | Guindon J et al. | β | 2006 | β |
| Targeted lipidomics: discovery of new fatty acyl amides. | Tan B et al. | β | 2006 | β |
| The emerging role of the endocannabinoid system in endocrine regulation and energy balance. | Pagotto U et al. | β | 2006 | β |
| The endocannabinoid system as an emerging target of pharmacotherapy. | Pacher P et al. | β | 2006 | β |
| Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor. | Hoi PM et al. | β | 2006 | β |
| Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. | Bouaboula M et al. | β | 2005 | β |
| A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons. | Price TJ et al. | β | 2005 | β |
| Brain regulation of food intake and appetite: molecules and networks. | Broberger C | β | 2005 | β |
| Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. | Fegley D et al. | β | 2005 | β |
| CLOCK/BMAL1 is involved in lipid metabolism via transactivation of the peroxisome proliferator-activated receptor (PPAR) response element. | Inoue I et al. | β | 2005 | β |
| Dissipating excess energy stored in the liver is a potential treatment strategy for diabetes associated with obesity. | Ishigaki Y et al. | β | 2005 | β |
| Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue. | Petersen G et al. | β | 2005 | β |
| Fatty acid amide hydrolase controls mouse intestinal motility in vivo. | Capasso R et al. | β | 2005 | β |
| Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. | Sun YX et al. | β | 2005 | β |
| Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. | Darmani NA et al. | β | 2005 | β |
| Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines. | Okamoto Y et al. | β | 2005 | β |
| Mechanisms of oleoylethanolamide-induced changes in feeding behavior and motor activity. | Proulx K et al. | β | 2005 | β |
| Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase. | Tsuboi K et al. | β | 2005 | β |
| N-acylphosphatidylethanolamine-hydrolyzing phospholipase D: a novel enzyme of the beta-lactamase fold family releasing anandamide and other N-acylethanolamines. | Ueda N et al. | β | 2005 | β |
| Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor gamma ligand. | Schopfer FJ et al. | β | 2005 | β |
| Novel time-dependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. | O'Sullivan SE et al. | β | 2005 | β |
| Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. | Fu J et al. | β | 2005 | β |
| Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1. | Wang X et al. | β | 2005 | β |
| Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways. | GonzΓ‘lez-Yanes C et al. | β | 2005 | β |
| Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity. | Corton JC et al. | β | 2005 | β |
| Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. | Tsuchida A et al. | β | 2005 | β |
| Phenotype-based treatment of dietary obesity: differential effects of fenofibrate in obesity-prone and obesity-resistant rats. | Ji H et al. | β | 2005 | β |
| Regional distribution and age-dependent expression of N-acylphosphatidylethanolamine-hydrolyzing phospholipase D in rat brain. | Morishita J et al. | β | 2005 | β |
| Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. | Jung KM et al. | β | 2005 | β |
| Structure and function of fatty acid amide hydrolase. | McKinney MK et al. | β | 2005 | β |
| The challenge of brain lipidomics. | Piomelli D | β | 2005 | β |
| The endocannabinoid system: physiology and pharmacology. | RodrΓguez de Fonseca F et al. | β | 2005 | β |
| The expanding field of cannabimimetic and related lipid mediators. | Bradshaw HB et al. | β | 2005 | β |
| The gut and energy balance: visceral allies in the obesity wars. | Badman MK et al. | β | 2005 | β |
| The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. | Lo Verme J et al. | β | 2005 | β |
| The search for the palmitoylethanolamide receptor. | LoVerme J et al. | β | 2005 | β |
| Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. | Movahed P et al. | β | 2005 | β |
| Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. | De Petrocellis L et al. | β | 2004 | β |
| A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet. | Cao J et al. | β | 2004 | β |
| Biochemical and morphological effects of K-111, a peroxisome proliferator-activated receptor (PPAR)alpha activator, in non-human primates. | SchΓ€fer SA et al. | β | 2004 | β |
| Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D. | Sun YX et al. | β | 2004 | β |
| Cannabinoids and neuroinflammation. | Walter L et al. | β | 2004 | β |
| Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. | Giuffrida A et al. | β | 2004 | β |
| Emerging aspects of pharmacotherapy for obesity and metabolic syndrome. | Nisoli E et al. | β | 2004 | β |
| Endocannabinoid receptor antagonists: potential for obesity treatment. | Kirkham TC et al. | β | 2004 | β |
| Fatty acid amide hydrolase in brain ventricular epithelium: mutually exclusive patterns of expression in mouse and rat. | EgertovΓ‘ M et al. | β | 2004 | β |
| Food intake is inhibited by oral oleoylethanolamide. | Nielsen MJ et al. | β | 2004 | β |
| Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. | Thorens B et al. | β | 2004 | β |
| Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARalpha and PPARgamma agonists. | Gervois P et al. | β | 2004 | β |
| N-cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase. | Tsuboi K et al. | β | 2004 | β |
| Oleamide: a member of the endocannabinoid family? | Fowler CJ | β | 2004 | β |
| Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). | GuzmΓ‘n M et al. | β | 2004 | β |
| Palmitoylputrescine, an antibiotic isolated from the heterologous expression of DNA extracted from bromeliad tank water. | Brady SF et al. | β | 2004 | β |
| Pharmaceutical approaches to the treatment of obesity. | Jandacek RJ et al. | β | 2004 | β |
| Potential modulation of plasma ghrelin and glucagon-like peptide-1 by anorexigenic cannabinoid compounds, SR141716A (rimonabant) and oleoylethanolamide. | Cani PD et al. | β | 2004 | β |
| Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome. | Luquet S et al. | β | 2004 | β |
| Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. | Gulyas AI et al. | β | 2004 | β |
| Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. | Terrazzino S et al. | β | 2004 | β |
| The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. | Clarke SD | β | 2004 | β |
| The vagus nerve--a common route for epilepsy therapies? | Cullingford T | β | 2004 | β |
| Anandamide hydrolysis: a new target for anti-anxiety drugs? | Gaetani S et al. | β | 2003 | β |
| Energy balance: a new role for PPARalpha. | Rosen ED | β | 2003 | β |
| The molecular logic of endocannabinoid signalling. | Piomelli D | β | 2003 | β |